There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

CHICAGO, April 24 (Reuters) - Thousands of Americans campaigning for the Novavax (NVAX.O), opens new tab COVID-19 booster got some good news this week: the FDA signaled it might still win approval ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine ... to speak on behalf of the FDA. Novavax had anticipated ...

But with FDA action, it would be the third vaccine against COVID-19 to receive full FDA approval, which could provide additional reassurance to people seeking the shot.The missed deadline came at ...

Products that receive emergency authorization can be removed by FDA after there is no longer a health emergency. All the COVID-19 vaccines used in the U.S. train the body to fight the coronavirus ...

Federal regulators are asking Novavax NVAX-5.66%decrease; red down pointing triangle to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval ...

“The FDA has now endorsed treating COVID with Ivermectin!” the company tweeted, with no mention that its attached news clip was 20 months old or that it was incorrect. It added: “How many ...